直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
    • AI + Finnegan
    • Appeals, Issues, and Legal Strategy
    • Diligence, Licensing, and Opinions
    • Global IP Enforcement, Litigation, and Trials
    • Patent Office Invalidation Proceedings
    • Prosecution and Portfolio Management
    • Trademark and Brand Management
    • AI, Electronics, and Information Technology
    • Chemicals, Industrials, and Materials
    • Communications
    • Consumer Goods and Services
    • Energy
    • Hospitality, Gaming, and Leisure
    • Life Sciences
    • Transportation and Logistics
  • Experience

Experience

Securing $240 million and a jury verdict of willful infringement for Promptu in patent case against Comcast

Promptu Systems Corporation

US Synthetic secures ITC exclusion order barring polycrystalline diamond compacts (PDCs)

US Synthetic Corporation

Achieving precedent in preserving valuable patents for Lumify®

Eye Therapies, LLC

Finnegan client Maglula delivers crushing blow to Amazon’s arbitration practices over counterfeit products

Maglula, Ltd.

Finnegan secures $180M for CSRC in complex arbitrations

CSRC et al.

Protecting a blockbuster diabetes treatment for AstraZeneca

AstraZeneca AB

Major victories across IP venues for Volkswagen, Audi, Bentley, and Lamborghini

Audi AG; Audi of America, LLC; Automobili Lamborghini America, LLC; Automobili Lamborghini S.p.A.; Bentley Motors Limited; Bentley Motors, Inc; Volkswagen AG; Volkswagen Group of America, Inc.

Finnegan tees up valuable patents for Eisai, leading to major strategic collaboration agreement

Eisai Co., Ltd.

Finnegan helps Intellia Therapeutics acquire Rewrite Therapeutics, Inc. for $45 million

Intellia Therapeutics, Inc.

Recent Experience

Experience

Rocket Pharmaceuticals, Inc. v. Lexeo Therapeutics, Inc., et al.

Rocket Pharmaceuticals, Inc. v. Lexeo Therapeutics, Inc., et al.

1:23-cv-09000, S.D.N.Y., Judges Castel, Aaron

Experience

Vifor (International) AG and American Regent, Inc. v. Mylan Labs. Ltd. et al. Vifor (International) AG and American Regent, Inc. v. Mylan Labs. Ltd. et al.

3:19-cv-13955, 3:19-cv-16305, D.N.J., Judges Wolfson, Arpert

Experience

Prosecuting patents for startup Hutchison Medipharma

Prosecuting patents for startup Hutchison Medipharma

Hutchison Medipharma

Experience

Finnegan tees up valuable patents for Principia Biopharma, leading to major acquisition deal

Finnegan tees up valuable patents for Principia Biopharma, leading to major acquisition deal Finnegan tees up valuable patents for Principia Biopharma, leading to major acquisition deal

Principia Biopharma

Experience

Biogen International GmbH v. Teva Pharmaceuticals USA, Inc. Biogen International GmbH v. Teva Pharmaceuticals USA, Inc.

1:17-cv-00829, D. Del., Judge Noreika
1:17-cv-00116, N.D.W. Va., Judge Keeley

Experience

Ferring B.V. v. Allergan, Inc. Ferring B.V. v. Allergan, Inc.

1:12-cv-02650, S.D.N.Y., Judges Cott, Sweet

Experience

Otsuka Pharmaceutical Co., Ltd. v. Apotex Corp. Otsuka Pharmaceutical Co., Ltd. v. Apotex Corp.

1:14-cv-01078, -04671, -02982, -07405, -05878, -06398 -08074 -03306, -06890, -05876, -08077, -03168, -07252, -07105 -05537, -03996, -06158, -04508, -04307, -06397, -07106, -01979, -03445; 1:15-cv-0161, -07584, -01585, -07803, -08830, -05109, -07802, -08955, -01716, -01967, -06353, -08305; 1:16-cv-05288, -05400, -05949, -07705 -02475, -02476, -08284, -05743, -00086, -08085, -00555, -00557, -07346, -06067, -00405, -00424, -05688, -09603; 1:17-cv-02754, -00392, D.N.J., Judges Simandle, Williams

Experience

Ferring B.V. v. Watson Laboratories, Inc. Ferring B.V. v. Watson Laboratories, Inc.

3:11-cv-00481, D. Nev., Judges Cooke, Jones, McKibben
2:15-cv-04222, D.N.J., Judges Chesler, Hayden, Waldor

Experience

Otsuka Pharmaceutical Co., Ltd. v. Teva Pharmaceuticals USA, Inc. Otsuka Pharmaceutical Co., Ltd. v. Teva Pharmaceuticals USA, Inc.

3:08-cv-01583, D.N.J., Judges Cooper, Goodman, Hughes

Experience

District court ruling maintains patent and regulatory protection of Otsuka’s Abilify® District court ruling maintains patent and regulatory protection of Otsuka’s Abilify®

3:07-cv-01000, D.N.J., Judges Cooper, Goodman, Hughes
11-1126, -1127, Fed. Cir., Judges Lourie, Moore, Reyna

Experience

A high-impact result for R&D licensing programs in the pharmaceutical industry A high-impact result for R&D licensing programs in the pharmaceutical industry

0:98-cv-07164; 0:00-cv-07057; 0:05-cv-60158, S.D. Fla., Judge Jordan
03-1354, -1355, -1386, -1387, Fed. Cir., Judges Michel, Lourie, Dyk

Experience

Aventis Pharma, S.A. v. Baxter Healthcare Corp. Aventis Pharma, S.A. v. Baxter Healthcare Corp.

1:06-cv-00636, D. Del., Judge Sleet

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP